Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp > Vertex Ada Poster

<< Previous

Bullboard Posts

Next >>

Post by MustangSalleyon May 31, 2022 9:57am

193 Views

Post# 34719720

Vertex Ada Poster

If you look at their poster Hba1c baseline levels for a severe hypoglycaemic are 8.6 and only reduced by one point . Whereas Sva patients had numbers go from 11 to 6 .

Vertex does not have really sick patients in their trial. Question is Why Fda halt their trial?

https://eppro02.ativ.me/src/EventPilot/php/express/web/planner.php?id=ADA22

MS

<< Previous

Bullboard Posts

Next >>

Barrick Gold employees detained in Mali amid ongoing dispute